Clinical trials
Chronic Kidney Disease on Hemodialysis clinical trials
Below are recruiting chronic kidney disease on hemodialysis clinical trials, each written for real people, not researchers. We’re tracking 112 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04671771Recruiting
Testing a new graft for hemodialysis access in kidney failure
This study tests whether an “AV graft” implant works safely and well for people with end-stage kidney disease who need hemodialysis. It may help your dialysis access last and work better, compared with current expectations for AV grafts.
Phoenix, ArizonaAges 18–90 - NCT06712654RecruitingPhase 2
Testing AP306 for high phosphate in dialysis patients
This trial tests a new medication called AP306 for people on hemodialysis who have high blood phosphate. It aims to see if the drug is safe, tolerable, and helps lower phosphate levels.
Huntsville, AlabamaAges 18 years+ - NCT05014178Recruiting
Kidney salt imaging scan with MRI
This study uses an MRI scan to look at how your kidneys handle salt (sodium). It may help researchers better understand kidney function in healthy people and in people with chronic kidney disease.
London, OntarioAges 18 years+ - NCT05266092Recruiting
Study kidney disease immune system activity in dialysis patients
This study looks at how the body’s defense systems (immune system and related signals) behave in people with chronic kidney disease. It may help doctors understand what is driving inflammation and related complications in dialysis patients.
OdenseAges 18 years+ - NCT05465044Recruiting
Twice-weekly dialysis vs three times for new dialysis patients
This trial tests whether starting hemodialysis more gently (2 times per week) is as safe and effective as the usual schedule (3 times per week) for people early in dialysis. It may help some patients feel better with fewer dialysis sessions while closely monitoring kidney-related measurements.
Long Beach, CaliforniaAges 18 years+ - NCT05515367RecruitingPhase 4
Real-world safety study of desidustat for kidney anemia
This study tracks the real-world safety of desidustat in adults with anemia caused by chronic kidney disease (CKD). It’s meant to see whether the medicine is safe when used in everyday care, not just in tightly controlled settings.
Sheikhpura, BiharAges 18–85 - NCT05642156Recruiting
Ultrafiltration versus usual dialysis in people on hemodialysis
This study compares a specific way of removing fluid during dialysis (isolated ultrafiltration) with conventional hemodialysis. It aims to see how each approach affects blood flow and fluid shifts in people with end-stage kidney disease.
GrazAges 18 years+ - NCT05656261Recruiting
Genetic testing study for African Americans
This study looks at genetic markers (genes) related to kidney risk in Black/African American adults. It may help researchers better understand who is at higher risk and how genetics could guide future care.
St Louis, MissouriAges 18–90 - NCT05970172RecruitingPhase 3
Roxadustat for anemia in kids with chronic kidney disease
This study tests roxadustat, a medicine that helps the body make more red blood cells, in children and teens with anemia caused by chronic kidney disease. It may help improve anemia and related blood counts, while also monitoring safety.
BrusselsAges 2–17 - NCT05997875Recruiting
Learning about dialysis access options
This study tests a new way to teach people about hemodialysis and the access (the spot in your arm or leg where the dialysis machine connects). It is for people with advanced kidney disease who are considering hemodialysis and want to learn about their options for vascular access.
Baltimore, MarylandAges 18 years+ - NCT06001827Recruiting
Study of a wrap to help new dialysis access points heal
This trial tests a special wrap placed around a new arm access point for dialysis (called an AV fistula) to see if it helps the access stay healthy and work better. It is for people who need a new AV fistula for kidney dialysis.
Bullhead City, ArizonaAges 18 years+ - NCT06288204Recruiting
Green Propolis and Royal Jelly for Kidney Health
This trial tests whether a supplement made from green propolis (a natural bee product) and royal jelly can help people with high blood pressure and chronic kidney disease. It aims to see if the supplement can improve kidney health and blood pressure control.
Rio de Janeiro, Rio de JaneiroAges 18–75 - NCT06311240Recruiting
Chronic pain therapy in hemodialysis patients
This study looks at whether a certain kind of therapy can help people on dialysis who have chronic pain. If you have kidney failure and have been on hemodialysis for at least 3 months, you may be able to join.
Terrassa, BarcelonaAges 18 years+ - NCT06324045Recruiting
Deprescribing medicines for kidney disease patients
This study looks at whether carefully reducing or stopping some medicines (deprescribing) can help people with advanced kidney disease. The goal is to improve quality of life and avoid side effects from unnecessary medications.
DohaAges 18 years+ - NCT06337838RecruitingPhase 3
Preventing blood loss during surgery in kidney patients
This trial tests two medications, tranexamic acid and desmopressin, to see if they can reduce bleeding during surgery in people with severe kidney disease or on dialysis. The results may help make surgery safer for you.
London, OntarioAges 18 years+ - NCT06343727Recruiting
Egg White Pudding for Low Protein in Kidney Dialysis
This trial tests whether eating a special high-protein egg white pudding every day for 12 weeks can help people on dialysis with low protein levels. It's for adults with chronic kidney disease who are on center-based hemodialysis and have a low blood protein level called albumin.
Winnipeg, ManitobaAges 18 years+ - NCT06438445Recruiting
Royal Jelly Supplement for Kidney Disease on Dialysis
This study tests whether a daily supplement called royal jelly can help people with chronic kidney disease who are on dialysis. Researchers will check if it improves health markers.
Rio de Janeiro, Rio de JaneiroAges 18–70 - NCT06960304Recruiting
Exercise program to help kidney patients' fistula work better
This trial tests if structured exercises can help the new blood vessel connection (AVF) in your arm mature properly for dialysis. It may improve your fistula's success and reduce complications.
Coimbra, Coimbra DistrictAges 18 years+ - NCT06635525Recruiting
How kidney failure affects your flu shot response
This study looks at how well the flu vaccine works in people with kidney failure who are on dialysis compared to healthy people. It will help doctors understand how kidney problems affect the body’s immune response to vaccination.
MilanAges 18–70 - NCT06635590Recruiting
Kidney disease, high potassium, and heart changes
This study looks at how high potassium levels (hyperkalemia) in people with chronic kidney disease may affect the heart. Doctors will use echocardiograms (heart ultrasounds) to check for changes.
AnkaraAges 18 years+ - NCT06660277Recruiting
Dialysis with expanded solute removal study
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
London, OntarioAges 45 years+ - NCT06671535Recruiting
Dialysis filter for itching in hemodialysis patients
This study tests a special type of dialysis filter (made of PMMA) to see if it can reduce severe itching and improve quality of life for people on long-term dialysis. If you have bothersome itching that standard treatment hasn't helped, this trial might be an option for you.
Saint PetersburgAges 18 years+ - NCT06676527Recruiting
Vorolanib for advanced kidney cancer after first treatment
This trial tests a targeted therapy pill, vorolanib, for people with advanced kidney cancer that has clear cell features and has gotten worse after initial treatment. It may offer a new option when standard second-line treatments are not working.
Nanjing, JiangsuAges 18–80 - NCT06752577Recruiting
Stem cell treatment for chronic kidney disease safety study
This study tests whether a single infusion of stem cells from bone marrow is safe for people with chronic kidney disease (CKD). It aims to see if this treatment can help slow kidney function loss.
Jacksonville, FloridaAges 18 years+
Hear when a new Chronic Kidney Disease on Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for chronic kidney disease on hemodialysis?
- Yes. Clin2 currently lists 112 recruiting chronic kidney disease on hemodialysis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a chronic kidney disease on hemodialysis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a chronic kidney disease on hemodialysis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.